|
 |
| home > pmps > spring 2003 > automated logistics for global distribution of clinical trial supplies |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
In February 2003, Fisher Clinical Services organised an open day to launch its new global distribution warehouse - a fully automated logistics centre in Horsham, UK, strengthening its distribution infrastructure alongside its facilities in Allentown, USA, Singapore and Basel, Switzerland.
Mr Stamm, could you give me an idea of the scale of the Horsham facility?
Our new facility comprises 2,000 GMP pallet locations, 9,500 automated locations, an automated picking system with a speed of six metres per second, eight automated picking stations and a processing capacity of 1,000 orders a day.
Why has Fisher built this large distribution centre?
The centre is part of Fisher's strategy to meet the demands of global clinical trials. We started as a clinical trial supplies packing company, but we are now moving towards becoming a supply chain management company. In this transition, distribution and site management of clinical trial supplies became very important pieces of the jigsaw.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
MipTec, October 14 – 16, 2008, Switzerland
MipTec about to take off by joining forces between Life Sciences Week, ALL-SystemsX.ch-Day, & Jobvector.com
More info >> |
|
 |
